Patent details

EP1926744 Title: CLOSTRIDIAL TOXIN ACTIVATABLE CLOSTRIDIAL TOXINS

Basic Information

Publication number:
EP1926744
PCT Application Number:
US2006035936
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068513498
PCT Publication Number:
WO2008008082
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CLOSTRIDIAL TOXIN ACTIVATABLE CLOSTRIDIAL TOXINS
French Title of Invention:
TOXINE CLOSTRIDIENNE ACTIVABLE PAR DES TOXINES CLOSTRIDIENNES
German Title of Invention:
MIT CLOSTRIDIENTOXIN AKTIVIERBARE CLOSTRIDIENTOXINE
SPC Number:

Dates

Filing date:
14/09/2006
Grant date:
07/04/2010
EP Publication Date:
04/06/2008
PCT Publication Date:
17/01/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/06/2008
EP B1 Publication Date:
07/04/2010
EP B2 Publication Date:
24/10/2018
EP B3 Publication Date:
Lapsed date:
14/09/2010
Expiration date:
14/09/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/10/2018
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
STEWARD, Lance, E.
Address:
United States (US)

2

Name:
OKA, Melvin, S.
Address:
United States (US)

Priority

Priority Number:
718616 P
Priority Date:
19/09/2005
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/33;

Publication

European Patent Bulletin

1

Issue number:
201827
Publication date:
04/07/2018
Description:
Title of invention Modified

2

Issue number:
201843
Publication date:
24/10/2018
Description:
Patent maintained (B2 publication)
Filing date Document type Number of pages